Are we there yet ? No, not yet, but getting really,

New Post Public Reply Private Reply Replies (1) Message Board
WBeacham
791
Are we there yet ?

No, not yet, but getting really, really close.

For the 2nd qtr 2021 it looks like we have a 3-fold increase in revenue from 1st qtr 2021, at a minimum (TAZZER, post #269042 on i-flub). This is coming on the heels of "... Q4 2020 revenue exceeded $519,000; an increase of 241% when compared to Q3 2020 revenue of ($151,956) aaaannnd reread this ... https://www.bielcorp.com/bioelectronics-corpo...forecasts/.

As Srinsocal (on i-flub, post #269087) has pointed out, this does not include any shipments to the Rest-of-the-World (ROW), eg - Europe & Asia. The CE Mark was re-certified on 12 Nov 2020, opening up sales to 33+ countries in Europe alone. It also obtained MDSAP certification in Q1 2021, which allows for product distribution in Canada, Australia, and New Zealand.

I reckon we get an update on the current situation in the week of 12 July, at the latest (11 days b4 the Olympics), however don't be surprised if it comes sooner. Or maybe some actual news, in addition to an update?!?!?! I am presuming these 2nd qtr 2021 revenue #'s (US & ROW) will make us profitable for the first time. The only thing better than that would be insurance coverage but all good things come to those who wait, right? Investors w/ any sense will want in on this in a very big way. Well, maybe not the 40 cent crowd, BBwwwaaaahaaahaaaaa !!!

Big Pharma (BP) has long arms, deep pockets, a nasty temper and is well-connected. They don't tolerate nor have any patience with upstarts or new-fangled gadgets that don't fit into their agenda (lots of examples). Like it or not, believe it or not, the FDA, in all of its self-imposed officialdom, is a wholly-owned subsidary of Big Pharma. It was created, in the first place, to act as an official cover for their drug concoctions; to give them an imprimatur of legitimacy. There is nobody who wants to believe otherwise more than myself. Look at who has headed the agency from day one to get verification or at the many of the so-called 'scandals' spanning decades. There are few, if any, 'mistakes' or 'poor decision-making'. The current opioid crisis is a prime example.

The medical field is loathe to innovation (again, lots of examples) unless it involves more pharmaceuticals, expensive surgeries, and more drugs, that's a given. The AMA took care of that decades ago with their decision to limit medical care to pills and surgery w/ few exceptions. Look up Morris Fishbein for an education. Not Wikipedia, dig a little deeper. As the saying goes - the truth is out there ... hint: it is well camouflaged and buried. The very same goes for the vaccine industry which has one of the most sordid histories one could ever imagine.

The point in bringing up all this unpleasant history is to put forth, perhaps, a more plausible backstory to our full body musculo-skeletal clearance. It would not have happened unless Big Pharma gave us, in the very least, a head nod, for it to go forward. Think of it as the 'Capo dei Capi' sanctioning, giving permission, so to speak, for it to proceed. Even gangsters can read the handwriting on the wall, to profit from societal trends. This 'go-ahead' has opened up everything and makes all things possibe going forward. In other words, we are on our way. Yes, I am including the real possibility of a buyout; post-profit and post-insurance coverage, of course.

If the decision had been made on the merits of the science and tech alone, we would have been cleared ten (10) yrs earlier, as it was in Canada. I mean, honestly, we got turned down b/c it worked better on one gender vs the other ??? It'd be laughable if it weren't so tragic. In today's world, that kind of malicious folderol passes for science. The ugly truth is BP had not made enough blood money on their opioid products. Opioid comes from Opium (ref: heroin). They knew all along, right from the gitgo, what they were doing.

Andy Whelan gave his life for (t)his company; that's commitment. He knew what so many of us now know. PEMF, and all of its' derivative technologies, is the future of medicine. Having the ability to 'see' the future in any given endeavor is the key to success. Our Founder, Andy, is still with us in spirit and enjoying every moment of it. His daughter, Kelly, our CEO, is soldiering on, doing all she can to further and enhance his legacy. Of this I have no doubt whatsoever, despite the ranting and raving of a few malcontents, nevermind their suspect motivations.

Electro-Magnetism (E/M) is THE key to everything. The Powers-That-Be w/in the BP community have known for decades the beneficial effect E/M has on the human body, including the brain. Actipatch (vibrational therapy) is but one example as are acupuncture, infrared saunas, and yoga. Western medicine, doled out to the masses that is, has always looked to overcome and conquer the body w/ drugs and surgery for obscene profits and marginal results. Far better to work with the body's own defenses and neural networks. Healthier outcomes, less disease & discomfort. Electroceuticals is the new paradigm and BP knows it better than most. Medical companies investing 100s of millions, all within about 5 yrs, is not a random event.

https://seekingalpha.com/instablog/21922151-b...onal-trial
Quote:
" ... Electroceuticals — The Next Billion Dollar Bioelectric Market

Electroceuticals are an exciting new area of therapeutics being pioneered by a growing list of companies. This rapidly growing market is projected to reach USD 33.14 billion by 2025, growing at a CAGR of 7.67% according to Kenneth Research.

As Time Magazine speculates, “Even with the still rudimentary efforts at stimulating some of the larger nerves in the body to treat, for example, headaches and chronic pain, financial analysts expect the market to reach $7 billion by 2025... "

Chakras, meridian lines, energy clusters, Hinduism third eye are concepts elusive to grasp. But we inflate a football with air we cannot see. So the air doesn't exist? We choose to believe one but not the others. How does acupuncture work? Should you decide to investigate E/M (inside and outside the human body) you will discover some very interesting info that could potentially rock your foundation to the core. Or is Plato's Cave your permanent home?

"The future belongs to those who recognize opportunities before they become obvious" - Oscar Wilde. We are the right company with the right e/m products in the right place at the right time. It is about to become very, very obvious.

I'm liking our chances - WBeacham
1

BioElectronics Corporation (BIEL) Stock Research Links

BIEL Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Aker BP's Q3 2026: Strong Earnings Fuel Optimism

Updated Category News Views 88

Third Quarter Overview: Riding the Wave Aker BP's third quarter report is a raucous symphony of successes that have the market nodding in admiration. Marking significant strides with their offshore projects, the company seems to be in a cavalier mood as it boasts higher sales volumes and promising financials. Net production came in at 374 mboepd, dampened slightly by...

Continue Reading
Eric Dalton: Redefining Homecare with Vision and Strategy

Updated Category News Views 73

What's Behind Eric Dalton's Continued Recognition? Now, if you told me a healthcare leader’s named 'Visionary of the Year' twice in a row, my first thought isn't 'stretch goals' but 'show me the goods.' And that’s precisely what Eric J. Dalton has done. The Vice President at Angels on Call Homecare isn't just tooting his own horn; he's building a damn symphony in the...

Continue Reading
Labcorp Lifts 2026 Guidance Amid Strong Q3 Performance

Updated Category News Views 179

Labcorp's Q3 Numbers Speak Loud and Clear Another quarter, another robust set of numbers for Labcorp (NYSE:LH). The company is strutting into the spotlight with third-quarter 2026 results that have investors nodding in approval. Revenue surged to $3.81 billion, marking a 6.9% increase from the prior year's $3.56 billion. And get this: adjusted EPS jumped 14.5%, clocking...

Continue Reading
DERMALOG Bolsters Biometric Defense with Key Wins

Updated Category News Views 81

DERMALOG Rides High with PAD Success Germany-based DERMALOG just gave biometric crooks a run for their money. In a testament to gutsy tech work, they've hit a homerun with the latest independent security evaluations. They’ve managed to spot and shut down all 1,500 tried and tested spoofs in presentation attacks—think photos, videos, and phony fingerprints. That’s no...

Continue Reading
ESENTIA Lifts EBITDA, Reduces Debt, Eyes Expansion

Updated Category News Views 62

ESENTIA Flexes Financial Muscles: What's the Deal? Walk with me through the gritty world of financials, and you’ll see that ESENTIA’s latest figures are a mixed bag with a tantalizing upside. We're talking about adjusted EBITDA ticking up to a cool $86 million in the third quarter of '26, a 1.3% lift from last year. Not too shabby, eh? Especially when you're grappling...

Continue Reading
Quad Sees Marginal Gains Amid Industry Challenges

Updated Category News Views 46

Treading Water with a Splash of Strategic Moves When you're in the thick of market shifts, sometimes it's not about big leaps but staying afloat with purpose. That's what Quad's recent financial release seems to hint at. A steady net sales figure hovering at $587 million for Q3 2026, barely a nudge compared to last year's numbers, sets the tone. It's not the fireworks...

Continue Reading
Arctic Wolf Leads in AI SOC: A 2026 Game Changer

Updated Category News Views 0

Leading the Pack with AI-Powered Security In the world of cybersecurity, where every day feels like a battlefield, Arctic Wolf has clawed its way to the top spot in the Q4 2026 QKS SPARK Matrix™ for AI SOC Automation. This recognition doesn't just highlight their prowess in handling security operations; it underscores their relentless commitment to infusing AI...

Continue Reading
AEP's $100B Power Plan: Investing in Tomorrow's Energy

Updated Category News Views 85

Electricity Powerhouse Unleashes Ambitious Plan If you thought American Electric Power (NASDAQ:AEP) was just cruising along, think again. This week, they rolled out an eye-popping $100 billion plan to supercharge their infrastructure and meet soaring electricity demands. It’s like they’re building the future of power right in front of our eyes. Third-quarter earnings...

Continue Reading
South Dakota's BEES Launch: Child Care Assistance Goes Live

Updated Category News Views 70

RedMane and South Dakota DSS: A New Milestone Talk about a leap into the digital age. South Dakota's Department of Social Services, teaming up with RedMane Technology, has just rolled out the Child Care Assistance Program on their BEES platform. That’s Benefits Eligibility and Enrollment System for those not keeping track. It represents a significant step in making life...

Continue Reading
CapCut Leads 2026 AI Image Tools for Creatives

Updated Category News Views 154

CapCut Emerges as a Go-To in AI Imagery There's no better feeling than striking gold in a flooded market. CapCut's got folks buzzing in 2026 for its top-tier AI image creation tools, according to Expert Consumers' latest rankings. On the surface, it might just seem like another tech gimmick, but dig a bit deeper, and you'll see why it's a game changer. From adland to...

Continue Reading

Top 5 Most Recently Viewed Articles

Understanding Market Sentiment for Parker Hannifin Corp

Updated Category News Views 146

Parker Hannifin Corp's Short Interest Trends Parker Hannifin Corp (NYSE: PH) has recently seen a notable change in its short interest. This essential metric refers to the number of shares that are sold short but not yet repurchased or closed out. Currently, short interest as a percentage of float has decreased by 7.76%, with approximately 1.35 million shares sold short,...

Continue Reading
Hemi Unveils $HEMI Token: A New Era for Bitcoin Programmability

Updated Category News Views 457

Hemi Launches $HEMI Token on Binance The Token Generation Event (TGE) marks a significant milestone for Hemi, following a recent funding round of $15 million, enhancing their total to $30 million. This massive investment underscores the growing confidence in the innovative programmability layer of Bitcoin offered by Hemi, set to redefine how we interact with...

Continue Reading
Ascend Performance Materials Embarks on Strategic Restructuring

Updated Category News Views 661

Ascend Performance Materials Initiates Restructuring Ascend Performance Materials, a key player in the production of high-quality engineered materials, has taken significant steps to enhance its financial standing. Through a supportive partnership with its lenders, the company is undergoing a restructuring process. This strategic decision will not only strengthen the...

Continue Reading
Marimekko Corporation Highlights Recent Managerial Transactions

Updated Category News Views 154

Insights into Marimekko Corporation's Recent Management Activities On a notable date in May, Marimekko Corporation announced important managerial transactions, marked by a key resolution at its recent Annual General Meeting. This meeting established that 40 percent of the annual remuneration for board members would be compensated with shares procured from the market. This...

Continue Reading
Blackboxstocks and REalloys Forge Major Rare Earth Partnership

Updated Category News Views 197

Strategic Partnership Announcement In an exciting development, Blackboxstocks Inc. (NASDAQ: BLBX) has revealed a substantial milestone for its merger target, REalloys Inc. This partnership aims to secure a 10-year offtake agreement with Critical Metals Corp. (NASDAQ: CRML), ensuring a steady supply of critical heavy rare earth elements from the Tanbreez Project in...

Continue Reading